Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
0,481 USD | -1,84% |
|
-16,78% | -15,61% |
30/05 | Day One Biopharmaceuticals vende il voucher di revisione prioritaria per 108 milioni di dollari | MT |
24/05 | VIRACTA THERAPEUTICS, INC. : Oppenheimer ottimista sul caso | ZM |
Attività
Numero di dipendenti: 40
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Mark Rothera
CEO | Chief Executive Officer | 61 | 19/09/22 |
Chief Tech/Sci/R&D Officer | - | - | |
Darrel Cohen
CTO | Chief Tech/Sci/R&D Officer | 59 | 07/08/23 |
Ayman El-Guindy
CTO | Chief Tech/Sci/R&D Officer | - | 06/07/21 |
Ivor Royston
BRD | Director/Board Member | 79 | 01/10/07 |
Ashleigh Barreto
IRC | Investor Relations Contact | - | 01/10/21 |
Melody Burcar
PRN | Corporate Officer/Principal | 41 | 01/09/22 |
Corporate Officer/Principal | - | 06/07/21 | |
Patric Nelson
PRN | Corporate Officer/Principal | - | 06/07/21 |
Cheryl A. Madsen
LAW | General Counsel | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Ivor Royston
BRD | Director/Board Member | 79 | 01/10/07 |
Thomas Darcy
BRD | Director/Board Member | 74 | 01/02/21 |
Barry Simon
BRD | Director/Board Member | 59 | 03/03/21 |
Mark Rothera
CEO | Chief Executive Officer | 61 | 19/09/22 |
Roger Pomerantz
CHM | Chairman | 67 | 01/06/20 |
Flavia Borellini
BRD | Director/Board Member | 65 | 14/08/21 |
Jane Barlow
BRD | Director/Board Member | 63 | 14/08/21 |
Stephen Rubino
BRD | Director/Board Member | 65 | 03/03/21 |
Sam Murphy
BRD | Director/Board Member | 47 | 01/01/19 |
Jane Chung
BRD | Director/Board Member | 53 | 10/08/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 39 272 434 | 38 184 370 ( 97,23 %) | 0 | 97,20 % |
Azione B | 0 | 10 248 | 0 | 0 |
Coordinate società
Viracta Therapeutics, Inc.
2533 South Coast Highway 101 Suite 210
92007, Cardiff
+
http://www.viracta.com![Indirizzo Viracta Therapeutics, Inc.(VIRX)](https://cdn.zonebourse.com/static/address/119601150.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-15,61% | 18,89 Mln | |
+16,59% | 44,44 Mrd | |
+41,02% | 40,03 Mrd | |
-10,62% | 37,68 Mrd | |
+29,92% | 31,46 Mrd | |
-9,23% | 27,29 Mrd | |
+12,34% | 26,29 Mrd | |
+41,53% | 13,8 Mrd | |
+31,49% | 12,46 Mrd | |
-7,40% | 11,26 Mrd |
- Borsa valori
- Azioni
- Azione VIRX
- Società Viracta Therapeutics, Inc.